Drug company AstraZeneca to cut 2,300 jobs in restructuring effort; sales have been hurt
LONDON – Struggling drug company AstraZeneca PLC says it will cut some 2,300 jobs worldwide as part of a restructuring plan.
The company said Thursday the cuts are in addition to a previously announced program cutting 1,600 positions related to research and development announced March 18 and the elimination of 1,150 positions announced last year.
A company statement indicates the elimination of these positions will result in a one-time $2.3 billion restructuring charge.
The company anticipates the cuts will produce benefits of about $800 million per year by 2016.
New CEO Pacal Soriot said the company’s goal is to be a global firm with a “focused portfolio in core therapy areas.”
The company’s finances have been hurt as generic competition has damaged sales.
News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community? Create a free account to comment on stories, ask questions, and join meaningful discussions on our new site.
Related Articles
Leave a Reply
You must be logged in to post a comment.